Icon revenues up ahead of Irish expansion

Revenues at Irish-headquartered drugs group Icon rose more than 10% to €353.8m in the first three months of the year as the firm prepares to take on 200 additional Irish staff. 

The roles which are to be based in Limerick and Dublin will come on stream following the creation of a new global innovation hub here.

The hub, announced earlier this year, will foster the development of technologies and clinical trial processes that will enable faster access to large volumes of clinical data with the roles to include those in IT, data analytics and clinical science among others.